Literature DB >> 863093

Factors influencing plasma drug concentrations.

D K Luscombe.   

Abstract

The usefulness of measuring plasma concentrations of drugs in patients is now well established and permits a greater efficacy and safety of treatment since dosage can be adjusted on an individual basis. In monitoring plasma concentrations one must recognize that a number of factors may influence these levels. For instance, levels may be affected by age, body-weight and size, genetical factors, abnormalities of water and electrolyte balance and complications associated with pathological conditions such as renal and hepatic impairment. Likewise, plasma levels will depend on dosage, time and route of drug administration, the bioavailability of the drug and time of blood sampling. In addition, absorption, distribution, metabolism, excretion and concurrent drug administration may profoundly affect plasma drug concentrations.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 863093

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  9 in total

1.  Management of depression in general practice.

Authors:  S Brandon
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-01

2.  Ethnicity and psychopharmacology.

Authors:  K M Lin; R E Poland; I M Lesser
Journal:  Cult Med Psychiatry       Date:  1986-06

Review 3.  Clinical pharmacokinetics of clomipramine.

Authors:  A E Balant-Gorgia; M Gex-Fabry; L P Balant
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

4.  A double-blind, randomized, placebo-controlled test of the effects of cannabidiol on fear elicited by a 10% carbon dioxide-enriched air breathing challenge.

Authors:  Ellen W Leen-Feldner; Teah-Marie Bynion; Graham M L Eglit; Marcel O Bonn-Miller; L Riley Gournay; Matthew T Feldner
Journal:  Psychopharmacology (Berl)       Date:  2022-10-15       Impact factor: 4.415

5.  Avatrombopag ethnic sensitivity analysis in chronic liver disease and thrombocytopenia patients: individual-level pooled analysis.

Authors:  Jun Lu; Brian D Jamieson; Ai-Min Hui
Journal:  Therap Adv Gastroenterol       Date:  2022-06-30       Impact factor: 4.802

Review 6.  A literature-based algorithm for the assessment, management, and monitoring of drug-induced QTc prolongation in the psychiatric population.

Authors:  M Zolezzi; L Cheung
Journal:  Neuropsychiatr Dis Treat       Date:  2018-12-24       Impact factor: 2.570

7.  Sex differences in medical cannabis-related adverse effects.

Authors:  Joshua Aviram; Gil M Lewitus; Yelena Vysotski; Paula Berman; Anna Shapira; Shiri Procaccia; David Meiri
Journal:  Pain       Date:  2022-05-01       Impact factor: 6.961

Review 8.  Weight-based dosing in medication use: what should we know?

Authors:  Sheng-Dong Pan; Ling-Ling Zhu; Meng Chen; Ping Xia; Quan Zhou
Journal:  Patient Prefer Adherence       Date:  2016-04-12       Impact factor: 2.711

9.  Effects of cannabidivarin (CBDV) on brain excitation and inhibition systems in adults with and without Autism Spectrum Disorder (ASD): a single dose trial during magnetic resonance spectroscopy.

Authors:  Charlotte M Pretzsch; Bogdan Voinescu; David Lythgoe; Jamie Horder; Maria Andreina Mendez; Robert Wichers; Laura Ajram; Glynis Ivin; Martin Heasman; Richard A E Edden; Steven Williams; Declan G M Murphy; Eileen Daly; Gráinne M McAlonan
Journal:  Transl Psychiatry       Date:  2019-11-20       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.